[Effectiveness of phytotherapy in supportive treatment of type 2 diabetes mellitus II. Fenugreek (Trigonella foenum-graecum)].

Keywords : []
Author : Fist_Author_Year_PM
47

Intensifying Insulin Therapy in Type 2 Diabetes: Choices & Challenges.

Keywords : ["type diabetes choice challenge", "intensify insulin therapy"]
Author : Fist_Author_Year_PM
44

Review of Clinical Profile of IDegAsp.

Keywords : ["clinical profile", "review", "idegasp"]
Author : Fist_Author_Year_PM
44

Overview of Clinical Trial Program and Applicability of Insulin Degludec/Insulin Aspart in Diabetes Management.

Keywords : ["insulin degludecinsulin aspart", "clinical trial program", "diabetes management", "overview", "applicability"]
Author : Fist_Author_Year_PM
44

Combination therapy of sodium-glucose co-transporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors in type 2 diabetes: rationale and evidences.

Keywords : ["type diabetes rationale", "sodiumglucose inhibitor", "dipeptidyl inhibitor", "combination therapy", "evidence"]
Author : Fist_Author_Year_PM
46

The benefits and risks of DPP4-inhibitors vs. sulfonylureas for patients with type 2 diabetes: accumulated evidence from randomised controlled trial.

Keywords : ["type diabetes accumulate evidence", "randomised control trial", "vs sulfonylureas", "risk", "patient", "benefit"]
Author : Fist_Author_Year_PM
109

Sodium-glucose co-transporter-2 inhibitors as add-on therapy to insulin: rationale and evidences.

Keywords : ["sodiumglucose inhibitor", "insulin rationale", "addon therapy", "evidence"]
Author : Fist_Author_Year_PM
45

Does tight control of systemic factors help in the management of diabetic retinopathy?

Keywords : ["systemic factor help", "tight control", "diabetic retinopathy", "management"]
Author : Fist_Author_Year_PM
11

Cardiovascular outcomes of sodium-glucose cotransporter 2 inhibitors: A comprehensive review of clinical and preclinical studies.

Keywords : ["sodiumglucose cotransporter inhibitor", "preclinical study", "comprehensive review", "cardiovascular outcome", "clinical"]
Author : Fist_Author_Year_PM
43

The cardiovascular phenotype: impact on choice of glucose- lowering therapy.

Keywords : ["glucose lower therapy", "cardiovascular phenotype impact", "choice"]
Author : Fist_Author_Year_PM
45